Lindsay Berry, Ph.D.
Senior Statistical Scientist
Lindsay Berry is a Senior Statistical Scientist at Berry Consultants, where she specializes in the design of Bayesian and adaptive clinical trials. She works across a broad range of therapeutic areas and development stages, from early phase dose-finding to well-controlled phase III trials and large-scale adaptive platform trials. Lindsay has been a key contributor to several international adaptive platform trials, particularly in infectious disease and critical care settings, and has authored over 30 publications, including articles in leading medical journals such as JAMA and NEJM. She earned her PhD in Statistical Science from Duke University, where her research focused on Bayesian modeling and forecasting of count time series.